Insight Guide

A Guide Through the API Drug Development Pipeline

04 APR 2023 Tuesday

Format: PDF file | Document type: Insight Guide | Promoted Content

This content is provided by Lonza Small Molecules, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

With the complexities associated with API and HPAPI drug development, it’s necessary to lean on the experts. With Q&A sections, insights and articles addressing the many challenges for biotechs, this eBook is your guide to navigating the drug development pipeline.

Latest content from Lonza Small Molecules

Paid for and in partnership with Lonza Small Molecules

Insights into creating an inhaler product through jet milling

Respiratory diseases require new treatments. Drug developers in the space can look to jet milling – a crucial process to create many dry powder inhaler products.

Paid for and in partnership with Lonza Small Molecules

Reducing the complexity of drug development through integrated services

Biotech companies face risks in drug development. Partnering with a CDMO that provides an integrated offering can reduce the potential for delays and greater expenses.

Paid for and in partnership with Lonza Small Molecules

The opportunity to de-risk drug development through PBPK

No company wants to progress a molecule through to the clinic only to suffer a bad readout. PBPK modeling services allow companies to predict what absorption challenges may arise in trials, and plan ways to mitigate them.

A Guide Through the API Drug Development Pipeline

Latest content from Lonza Small Molecules

Insights into creating an inhaler product through jet milling

Reducing the complexity of drug development through integrated services

The opportunity to de-risk drug development through PBPK

Related resources from Lonza Small Molecules

Supplier info centre

For more product information visit Lonza Small Molecules's information centre

Outsourcing-Pharma

Resources